论文部分内容阅读
目的 探讨双黄连、川芎嗪治疗慢性肺心病急性发作期的疗效。方法 治疗组 32例在常规西药治疗基础上加用双黄连和川芎嗪注射液 ,并与只应用常规西药治疗的 30例作对照。结果 治疗组的显效率为 6 2 5 % ,总有效率为 90 6 % ;对照组的显效率为 30 % ,总有效率为 6 3 3%。治疗组的临床显效率、总有效率、血气分析指标改善情况均显著优于对照组 (P <0 0 5 )。结论 加用双黄连和川芎嗪的中西医结合疗法对肺心病急性发作期疗效显著。
Objective To investigate the curative effect of Shuanghuanglian and ligustrazine on patients with acute episode of chronic pulmonary heart disease. Methods 32 cases of treatment group on the basis of conventional Western medicine plus Shuanghuanglian and ligustrazine injection, and only the application of conventional Western medicine for 30 cases as a control. Results The effective rate of the treatment group was 62.5%, the total effective rate was 90.6%. The effective rate of the control group was 30% and the total effective rate was 63.3%. The clinical effective rate, total effective rate and improvement of blood gas analysis indexes in the treatment group were significantly better than those in the control group (P <0.05). Conclusion Integrative treatment with Shuanghuanglian and ligustrazine has a significant effect on acute episodes of pulmonary heart disease.